The work in this laboratory includes two major projects: 1) Assessment of alterations in the immune response brought about through the administration of passively administered alloantibody. The effects of alloantibody on retransplanted skin grafts is currently under investigation. 2) Studies on the use of activated cells to destroy tumor cells both in vivo and in vitro are underway. Biological response modifiers used to activate tumor cells include interleukin-2 and gamma interferon. An adjuvant immunotherapeutic attack on cancer cells remaining after surgery is planned using in vitro activated cells.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CM006652-10
Application #
3963284
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Cancer Treatment
Department
Type
DUNS #
City
State
Country
United States
Zip Code